NCT03881787View on ClinicalTrials.gov

Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux

PHASE1UnknownINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

October 30, 2019

Study Completion Date

December 30, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

anti-EGFR monoclonal antibody

Recombinant anti-EGFR human mouse chimeric monoclonal antibody injection

DRUG

Cetuximab injection

Cetuximab injection

Trial Locations (2)

Unknown

RECRUITING

Shanghai Public Health Clinical Center, Shanghai

RECRUITING

West China Hospital, Chengdu

Sponsors
All Listed Sponsors
collaborator

West China Hospital

OTHER

collaborator

Shanghai Public Health Clinical Center

OTHER_GOV

lead

Dragonboat Biopharmaceutical Company Limited

INDUSTRY